搜索临床试验以:Analysis of early immune modifications
总计8996个结果
-
Mayo ClinicNational Cancer Institute (NCI)完全的转移性三阴性乳腺癌 | IV 期乳腺癌 AJCC v6 和 v7 | III 期乳腺癌 AJCC v7 | IIIA 期乳腺癌 AJCC v7 | IIIB 期乳腺癌 AJCC v7 | IIIC 期乳腺癌 AJCC v7 | 乳腺癌美国
-
Sheba Medical CenterWeizmann Institute of Science未知
-
Trakya UniversityCommission of Scientific Research Projects of Trakya University (TÜBAP)完全的
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Singapore General HospitalDuke-NUS Graduate Medical School; Singapore Clinical Research Institute; Health Promotion Board... 和其他合作者完全的
-
National Center of Cardiology and Internal Medicine...完全的
-
Tata Memorial CentreIndian Statistical Institute, Kolkata主动,不招人
-
Hackensack Meridian HealthUppsala University, Sweden (Department of Immunology, Genetics and Pathology)暂停
-
Vanderbilt University Medical CenterNational Institute of General Medical Sciences (NIGMS)终止
-
Federico II University邀请报名Prevention of Clinical Symptoms in Celiac Disease意大利
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo完全的
-
Centre Hospitalier Universitaire de Nice完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人Nivolumab 联合 Trametinib 和 Dabrafenib,或 Encorafenib 和 Binimetinib 治疗 BRAF 突变的转移性或不可切除的 III-IV 期黑色素瘤患者转移性黑色素瘤 | III 期皮肤黑色素瘤 AJCC v7 | IV 期皮肤黑色素瘤 AJCC v6 和 v7 | IIIC 期皮肤黑色素瘤 AJCC v7 | 不可切除的黑色素瘤 | 脑转移性恶性肿瘤 | IIIA 期皮肤黑色素瘤 AJCC v7 | IIIB 期皮肤黑色素瘤 AJCC v7美国
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
University of ArizonaUniversity of Southern California; Alzheimer's Association主动,不招人
-
Vanderbilt University Medical CenterNational Cancer Institute (NCI)完全的
-
Pacific Coast Family Medical Group邀请报名癌症 | 动脉粥样硬化 | 心房颤动 | 胰岛素抵抗 | 失智 | 糖尿病前期 | 2型糖尿病 | NASH - 非酒精性脂肪性肝炎 | 舒张功能障碍 | 颈动脉斑块
-
Groupe Hospitalier Pitie-SalpetriereInstitut National de la Santé Et de la Recherche Médicale, France完全的